SCHEMBL6004190

SCHEMBL6004190

CC(C)(C)OC(=O)Nc1cc(Cl)c(Cl)cc1I

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 1/20 0.39
▸ HSP90AB1 P08238 1/20 0.39
▸ ATR Q13535 1/20 0.39
▸ CA12 O43570 2/20 0.38
▸ CA1 P00915 2/20 0.38
▸ CA9 Q16790 2/20 0.38
▸ CA2 P00918 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.37
▸ LCK P06239 2/20 0.36
▸ BRD9 Q9H8M2 1/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ NFKB2 Q00653 1/20 0.36
▸ RELA Q04206 1/20 0.36
▸ CYP17A1 P05093 1/20 0.35
▸ METAP1 P53582 1/20 0.34
▸ BRD4 O60885 1/20 0.34
▸ P2RX7 Q99572 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30369522 0.88 CA12 (0.38) HSP90AA1HSP90AB1ATRCA12CA1
SCHEMBL13247607 0.85 CA12 (0.43) HSP90AA1HSP90AB1ATRCA12CA1
SCHEMBL15677015 0.81 HSP90AA1 (0.45) HSP90AA1HSP90AB1ATR
SCHEMBL12225275 0.81 HSP90AA1 (0.45) HSP90AA1HSP90AB1ATRCYP17A1
SCHEMBL3571997 0.81 CA12 (0.41) HSP90AA1HSP90AB1ATRCA12CA1
SCHEMBL1581324 0.80 ATR (0.42) ATRBRD9CYP17A1METAP1
SCHEMBL15584205 0.80 ATR (0.42) ATRCA12CA1CA9CA2
SCHEMBL29364468 0.80 ATR (0.42) ATRBRD9CYP17A1METAP1
SCHEMBL7416727 0.78 HSP90AA1 (0.45) HSP90AA1HSP90AB1ATRCA12CA1
SCHEMBL30048786 0.78 RXFP1 (0.43) HSP90AA1HSP90AB1RXFP1BRD9METAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060205751-A1 Novel compounds SMITHKLINE BEECHAM CORPORATION (US) 2006-09-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060205751-A1 Novel compounds KCNN2, KCNN3, KCNN1 HSP90AA1 4271/4885HSP90AB1 3974/4885ATR 4526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback